Promisia Healthcare Limited logo

Promisia Healthcare Interim Results

Half Year Results27 November 2023PHLHealthcare

Interim Report
FOR THE SIX MONTHS

ENDED 30 SEPTEMBER 2023

2
PROMISIA HEALTHCARE LIMITED

Half Year Snapshot 4
Chair’s Report 5

Unaudited Consolidated Interim Financial Statements

Condensed Consolidated Statement of Comprehensive Income 8

Condensed Consolidated Statement of Financial Position 9

Condensed Consolidated Statement of Changes in Equity 10

Condensed Consolidated Statementof Cash Flows 11

Notes to the Condensed Consolidated Statements 12

Directory 20

3

INTERIM REPORT

Half Year Snapshot
For the six months ending 30 September 2023

Strategic Progress

• Welcomed new Board leadership with

appointment of industry expert, Rhonda Sherriff,

as Chair

• Restructured and strengthened the leadership

team with appointment of Karen Lake as Group

GM, along with new GM of Finance and new

Clinical and Quality Manager

• Review of strategy and reset of objectives to drive

commercial growth

• Continuing improvement in occupancy across

the Group

• Continue to explore expansion and growth

opportunities

Financial Snapshot

• Revenue $12.9m ▲ 11%

• EBITDAF

1

$1.6m ▼ 11%

• Net Loss After Tax $(152)k, down from a profit

of $382k in prior year, reflecting one-off costs

associated with the leadership and Board

transition

• Total assets $73.6m ▲ 12%

• Borrowings $30.4m ▲ 2%

Promisia is a New Zealand-based aged

care and retirement living provider,

with a focus on delivering quality

personalised care. Our aim is to be

the aged care provider of choice in our

communities.

Our strategy is founded on identified pathways

which we believe will deliver long term growth.

1

EBITDAF is operating earnings before interest, tax, depreciation,

amortisation and fair value adjustments and is a non-GAAP number.

Stronger

Business

Invest in our business

and our people, creating

a robust scalable

platform for growth, with

strong leadership and

governance

Maximise

Occupancy

Grow revenue through

offering quality care to

maximise occupancy at

existing and future facili-

ties; and repurposing beds

as needed to meet market

demand

Diverse

Revenue Streams

Increase the focus on

independent living

options, broaden the

range of services at

each facility and increase

the number of higher

acuity beds

Network

Expansion

Grow our network

through strategically

located value-accretive

acquisitions, brownfield

and greenfield

developments

4

PROMISIA HEALTHCARE LIMITED

Chair’s Report
Dear Shareholder

I am pleased to report to you for the first time since

commencing as Chair of Promisia in August this year.

Throughout the first half of the 2024 financial year

(1H 2024), we continued to focus on our commercial

objectives, delivering increasing occupancy, strong new

villa sales and resales, and a relentless focus on high

quality, personalised care.

Over the past six months, we have refreshed and

strengthened our Board and transitioned to a new,

restructured leadership team. We were pleased to

welcome Jill Hatchwell to the board as an independent

director in August 2023. Jill has extensive financial and

corporate governance experience in both public and

private companies and has been appointed chair of

Promisia’s Audit and Risk Management Committee.

We now have high quality, very experienced people

governing and managing your business. This has

provided an opportunity to revisit our strategy and

commercial objectives. We have reconfirmed our

four strategic pathways and management has set out

a strong plan to achieve our goals, which has been

endorsed by the Board. While the first half of the year

was a time of transition, we now have a strong platform

in place and expect to see benefits start to flow through

from the second half of the financial year.

Financial Performance

1H 2024 revenue increased to $12.9m as a result of

rising occupancy and increasing deferred management

fees from the sale of independent villas.

Expenses increased year on year, however a large

portion of the additional administration expenses are

considered to be one-off in nature as they relate to

the recruitment of the leadership team and additional

consultant costs during the transition period.

Inflation, higher interest rates and increased wage costs

were also factors in the uplift in expenses and had a

downward impact on cashflow. Cash at period end was

$364k, down from $2.1m at 31 March 2023.

Borrowings reduced slightly to $30.4m with principal

repayments from cashflows. Promisia has commenced a

review of its banking facilities, with the objectives being

to consolidate borrowings, reduce funding costs and

adjust covenants to be appropriate for Promisia in the

prevailing market conditions.

The company reported a net loss after tax of $(152)k for

1H 2024, however, is expecting a return to profit for the

full year.

Stronger Business

One of the highlights of the past six months has been

the development of a strengthened leadership team.

We were particularly pleased to welcome Karen Lake

as Promisia’s new Group General Manager in August

2023. Karen has extensive experience in the aged care,

retirement and healthcare sectors, having worked for

NZX listed providers, Oceania and Ryman Healthcare

for a number of years. She brings a passion for

excellence, innovative thinking and extensive industry

knowledge.

Karen has continued to build the strength of the

leadership team, with the appointment of Francisco

Rodriguez Ferrere as the new GM Finance and Blesster

Saga as the new Clinical and Quality Manager. Blesster

comes into a newly created role that separates clinical

and operational management of our business, with long

standing team member, Virginia Dyall-Kalidas, taking

on the role of Group Operations Manager. All these

individuals have a track record of excellence in their

fields, are passionate about the aged care industry and

will play an important role as we grow the business and

shareholder value.

Promisia is now well positioned with a strong Board and

management team to take the company forward and

achieve our goals. We have a stable workforce and have

seen labour pressures ease, with positive recruitment

and retention of our people. This in turn has a positive

impact on resident satisfaction.

5

INTERIM REPORT

Focus on Care
Providing high quality care that is sensitive and

appropriate to people’s individual requirements is at

the core of our business. The appointment of a Clinical

and Quality Manager further cements our commitment

to care, with a refresh of clinical processes and

procedures, reporting and investment in continuous

training to enhance our care delivery. We are pleased to

have received payment and an increase in funding from

Manatū Hauora Ministry of Health which enables us to

offer a competitive rate to retain our registered nurse

workforce .

Outlook

Good progress is being made and Promisia is well

positioned to take advantage of market opportunities.

The care sector and funding thereof continue to be

challenging; however, we are committed to ensuring our

communities continue to have access to high quality

care.

The investments we are making into our business will

deliver long term gains and benefits. Our business is

in good shape, with a strong and experienced Board

and management team, and we are looking forward

to delivering another year of increased earnings and

business growth in FY24.

Ngā mihi

Rhonda Sherriff

Chair

Maximise Occupancy

Maximising occupancy at all our facilities continues

to be a priority, with increased sales resource and

management focus dedicated to our efforts. We have

continuing local demand for our facilities in Fielding

and Dannevirke, and Aldwins House in Christchurch is

steadily filling up. There has been strong demand for

the new villas at Ranfurly Manor village, with 30 of the

32 new villas either under contract, sold or occupied.

Diverse Revenue Streams

In addition to our standard care and accommodation

offers, we offer premium care suites, which carry an

additional supplement in return for greater space,

amenities and aesthetics. Following the success of

the Ranfurly Manor village development, we will also

continue to consider opportunities to develop more

independent living units (villas and apartments), with

occupational rights agreements and management fees

paid for by the resident.

One of our key strengths is the ability to respond and

reconfigure our facilities to meet the needs of our

communities. Our skills, focus on care excellence and

dedicated staff allow us to provide for a range of care

needs, from low level to high needs and other specialist

care services. This helps to ensure occupancy levels are

maximised across our facilities.

Network Expansion

Following several land acquisitions in FY23, we continue

to explore opportunities to either strategically add to

our land bank or acquire facilities with development

potential or that offer strong returns.

6

PROMISIA HEALTHCARE LIMITED

Unaudited Consolidated Interim
Financial Statements

FOR THE SIX MONTHS ENDED

30 SEPTEMBER 2023

7

INTERIM REPORT

PROMISIA HEALTHCARE LIMITED
CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2023

Note

30 September

2023

UNAUDITED

30 September

2022

UNAUDITED

$ '000$ '000

Revenue and other income

Revenue 12,92611,673

12,92611,673

Less: expenses

Administration expenses(2,024)(1,315)

Operational expenses(9,306)(8,555)

Depreciation(386)(409)

Finance costs(1,339)(1,047)

(13,055)(11,326)

Profit / (loss) before income tax expense(129)347

Income tax (expense) / credit(23)35

Net profit / (loss) from continuing operations(152)382

Total other comprehensive income--

Total comprehensive income gain / (loss)

(152)382

Earnings per share (cents per share)

Basic & diluted earnings per share from continuing

operations 7 (0.0007) 0.0018

The accompanying notes form part of these condensed consolidated financial statements.

- 2 -

PROMISIA HEALTHCARE LIMITED

CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2023

Note

30 September

2023

UNAUDITED

30 September

2022

UNAUDITED

$ '000$ '000

Revenue and other income

Revenue 12,92611,673

12,92611,673

Less: expenses

Administration expenses(2,024)(1,315)

Operational expenses(9,306)(8,555)

Depreciation(386)(409)

Finance costs(1,339)(1,047)

(13,055)(11,326)

Profit / (loss) before income tax expense(129)347

Income tax (expense) / credit(23)35

Net profit / (loss) from continuing operations(152)382

Total other comprehensive income--

Total comprehensive income gain / (loss)

(152)382

Earnings per share (cents per share)

Basic & diluted earnings per share from continuing

operations 7 (0.0007) 0.0018

The accompanying notes form part of these condensed consolidated financial statements.

- 2 -

CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

For the six months ended 30 September 2023

PROMISIA HEALTHCARE LIMITED

CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION

AS AT 30 SEPTEMBER 2023

Note

30 September

2023

UNAUDITED

30 September

2022

UNAUDITED

31 March

2023

AUDITED

$ '000$ '000$ '000

Assets

Cash and cash equivalents3642,2162,059

Trade receivables and other assets2,2792,2051,827

Related party advances8145538145

Current tax assets7-6

Property, plant and equipment217,70117,25117,910

Investment properties352,64643,27549,320

Deferred tax assets472394494

Total assets73,61465,87971,761

Liabilities

Trade and other payables3,4533,2353,695

Revenue received in advance1,6491,1131,472

Current tax liabilities-169-

Related party payables8175-175

Borrowings430,43129,84730,872

Occupancy rights agreements17,97012,55415,459

Total liabilities53,67846,91851,673

Net assets

19,93618,96120,088

Equity

Share capital577,42677,27677,426

Reserves6(50)(717)(50)

Accumulated losses(57,440)(57,598)(57,288)

Total equity

19,93618,96120,088

Net tangible asset backing per share (cents) 0.0910.0870.092

Signed

on behalf of the board of directors, dated

Director:

Rhonda Sherriff

Director:

Thomas Brankin

The accompanying notes form part of these condensed consolidated financial statements.

- 3 -

8

PROMISIA HEALTHCARE LIMITED

PROMISIA HEALTHCARE LIMITED
CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION

AS AT 30 SEPTEMBER 2023

Note

30 September

2023

UNAUDITED

30 September

2022

UNAUDITED

31 March

2023

AUDITED

$ '000$ '000$ '000

Assets

Cash and cash equivalents3642,2162,059

Trade receivables and other assets2,2792,2051,827

Related party advances8145538145

Current tax assets7-6

Property, plant and equipment217,70117,25117,910

Investment properties352,64643,27549,320

Deferred tax assets472394494

Total assets73,61465,87971,761

Liabilities

Trade and other payables3,4533,2353,695

Revenue received in advance1,6491,1131,472

Current tax liabilities-169-

Related party payables8175-175

Borrowings430,43129,84730,872

Occupancy rights agreements17,97012,55415,459

Total liabilities53,67846,91851,673

Net assets

19,93618,96120,088

Equity

Share capital577,42677,27677,426

Reserves6(50)(717)(50)

Accumulated losses(57,440)(57,598)(57,288)

Total equity

19,93618,96120,088

Net tangible asset backing per share (cents) 0.0910.0870.092

Signed on behalf of the board of directors, dated

Director:

Rhonda Sherriff

Director:

Thomas Brankin

The accompanying notes form part of these condensed consolidated financial statements.

- 3 -

PROMISIA HEALTHCARE LIMITED

CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2023

Note

30 September

2023

UNAUDITED

30 September

2022

UNAUDITED

$ '000$ '000

Revenue and other income

Revenue 12,92611,673

12,92611,673

Less: expenses

Administration expenses(2,024)(1,315)

Operational expenses(9,306)(8,555)

Depreciation(386)(409)

Finance costs(1,339)(1,047)

(13,055)(11,326)

Profit / (loss) before income tax expense(129)347

Income tax (expense) / credit(23)35

Net profit / (loss) from continuing operations(152)382

Total other comprehensive income--

Total comprehensive income gain / (loss)

(152)382

Earnings per share (cents per share)

Basic & diluted earnings per share from continuing

operations 7 (0.0007) 0.0018

The accompanying notes form part of these condensed consolidated financial statements.

- 2 -

CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION

As at 30 September 2023

PROMISIA HEALTHCARE LIMITED

CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION

AS AT 30 SEPTEMBER 2023

Note

30 September

2023

UNAUDITED

30 September

2022

UNAUDITED

31 March

2023

AUDITED

$ '000$ '000$ '000

Assets

Cash and cash equivalents3642,2162,059

Trade receivables and other assets2,2792,2051,827

Related party advances8145538145

Current tax assets7-6

Property, plant and equipment217,70117,25117,910

Investment properties352,64643,27549,320

Deferred tax assets472394494

Total assets73,61465,87971,761

Liabilities

Trade and other payables3,4533,2353,695

Revenue received in advance1,6491,1131,472

Current tax liabilities-169-

Related party payables8175-175

Borrowings430,43129,84730,872

Occupancy rights agreements17,97012,55415,459

Total liabilities53,67846,91851,673

Net assets

19,93618,96120,088

Equity

Share capital577,42677,27677,426

Reserves6(50)(717)(50)

Accumulated losses(57,440)(57,598)(57,288)

Total equity

19,93618,96120,088

Net tangible asset backing per share (cents) 0.0910.0870.092

Signed

on behalf of the board of directors, dated

Director:

Rhonda Sherriff

Director:

Thomas Brankin

The accompanying notes form part of these condensed consolidated financial statements.

- 3 -

Signed on behalf of the board of directors, dated 28 November 2023

9

INTERIM REPORT

PROMISIA HEALTHCARE LIMITED
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2023

Note

Contributed

equityReserves

Accumulated

LossesTotal equity

$ '000$ '000$ '000$ '000

Consolidated

Balance as at 1 April 2022

77,276(717)(57,980)18,579

Profit for the period--382382

Other comprehensive income for

the 6 months----

Total comprehensive income for

the period--382382

Balance as at 30 September 2022

(UNAUDITED)

77,276(717)(57,598)18,961

Balance as at 1 April 2023

77,426(50)(57,288)20,088

Loss for the period--(152)(152)

Other comprehensive income for

the 6 months----

Total comprehensive income for

the period--(152)(152)

Balance as at 30 September 2023

(UNAUDITED)

77,426(50)(57,440)19,936

The accompanying notes form part of these condensed consolidated financial statements.

- 4 -

PROMISIA HEALTHCARE LIMITED

CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2023

Note

30 September

2023

UNAUDITED

30 September

2022

UNAUDITED

$ '000$ '000

Revenue and other income

Revenue 12,92611,673

12,92611,673

Less: expenses

Administration expenses(2,024)(1,315)

Operational expenses(9,306)(8,555)

Depreciation(386)(409)

Finance costs(1,339)(1,047)

(13,055)(11,326)

Profit / (loss) before income tax expense(129)347

Income tax (expense) / credit(23)35

Net profit / (loss) from continuing operations(152)382

Total other comprehensive income--

Total comprehensive income gain / (loss)

(152)382

Earnings per share (cents per share)

Basic & diluted earnings per share from continuing

operations 7 (0.0007) 0.0018

The accompanying notes form part of these condensed consolidated financial statements.

- 2 -

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

For the six months ended 30 September 2023

10

PROMISIA HEALTHCARE LIMITED

PROMISIA HEALTHCARE LIMITED
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2023

30 September

2023

UNAUDITED

30 September

2022

UNAUDITED

$ '000$ '000

Cash flow from operating activities

Receipts from residents for care fees and services12,51211,232

Receipts of residents' loans from new sales4,0332,215

Payments to suppliers and employees(12,247)(9,845)

Repayments of residents' loans(883)(595)

Interest paid(1,339)(1,047)

Income tax paid(2)(28)

Net cash provided by operating activities2,0741,932

Cash flow from investing activities

Payment for property, plant and equipment(177)(13,560)

Payment for investment property(3,326)(1,260)

Net cash used in investing activities(3,503)(14,820)

Cash flow from financing activities

Repayment of related party advance-20

Net proceeds from / (repayment of) borrowings(266)12,673

Net cash provided by / (used in) financing activities(266)12,693

Reconciliation of cash

Cash at beginning of the financial period2,0592,411

Net decrease in cash held(1,695)(195)

Cash at end of financial period

3642,216

The accompanying notes form part of these condensed consolidated financial statements.

- 5 -

PROMISIA HEALTHCARE LIMITED

CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2023

Note

30 September

2023

UNAUDITED

30 September

2022

UNAUDITED

$ '000$ '000

Revenue and other income

Revenue 12,92611,673

12,92611,673

Less: expenses

Administration expenses(2,024)(1,315)

Operational expenses(9,306)(8,555)

Depreciation(386)(409)

Finance costs(1,339)(1,047)

(13,055)(11,326)

Profit / (loss) before income tax expense(129)347

Income tax (expense) / credit(23)35

Net profit / (loss) from continuing operations(152)382

Total other comprehensive income--

Total comprehensive income gain / (loss)

(152)382

Earnings per share (cents per share)

Basic & diluted earnings per share from continuing

operations 7 (0.0007) 0.0018

The accompanying notes form part of these condensed consolidated financial statements.

- 2 -

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

For the six months ended 30 September 2023

11

INTERIM REPORT

PROMISIA HEALTHCARE LIMITED
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE 6 MONTHS ENDED 30 SEPTEMBER 2023

NOTE 1: STATEMENT OF SIGNIFICANT ACCOUNTING POLICIES

The condensed consolidated financial statements presented are those of Promisia Healthcare Limited (the

Company), and its subsidiaries (the Group). Promisia Healthcare Limited is a profit-oriented entity

incorporated in New Zealand. Promisia Healthcare Limited’s principal activities are the ownership and

operation of retirement villages, rest homes, and hospitals for the elderly within New Zealand.

Promisia Healthcare Limited is a Financial Markets Conduct Act reporting entity under the Financial

Reporting Act 2013 and the Financial Markets Conduct Act 2013.

These condensed consolidated financial statements have been approved for issue by the Board of Directors

on

(a) Basis of preparation of the condensed financial report

The condensed consolidated financial statements comprise the following: condensed consolidated

statement of comprehensive income, condensed consolidated statement of financial position, condensed

consolidated statement of changes in equity, condensed consolidated statement of cash flows, and

condensed accounting policies and notes to the condensed consolidated financial statements.

These condensed consolidated financial statements have been prepared in accordance with NZ IAS 34

Interim Financial Reporting, and should be read in conjunction with the Groups' last consolidated financial

statements as at and for the year ended 31 March 2023 (‘last annual financial statements’). These do not

include all of the information required for a complete set of NZ IFRS financial statements. However,

selected explanatory notes are included to explain events and transactions that are significant to an

understanding of changes in the Groups' financial position and performance since the last consolidated

financial statements.

The Group's accounting policies have been applied consistently to all periods presented in these condensed

financial statements.

The information is presented in New Zealand dollars, the Group’s functional and presentation currency, and

rounded to the nearest thousand dollars unless stated otherwise.

There is no seasonality or cyclically of the operations.

(b) Going concern

The condensed consolidated financial statements have been prepared on a going concern basis, which

contemplates continuity of normal business activities and the realisation of assets and the settlement of

liabilities in the ordinary course of business.

The Directors are comfortable that based on the historic performance, detailed cash flow projections, and

the support provided by Directors, the Group will be able to meet their cash flow requirements as they fall

due. The Group has reported a net loss before tax of $0.129 million.

- 6 -

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENT

For the six months ended 30 September 2023

12

PROMISIA HEALTHCARE LIMITED

28 November 2023.

PROMISIA HEALTHCARE LIMITED
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE 6 MONTHS ENDED 30 SEPTEMBER 2023

NOTE 1: STATEMENT OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

(b) Going concern (Continued)

On 16 November 2023, the Group advised that it had breached the EBITDA / Interest banking covenant for

the quarter ended 30 September 2023 for loans held with Bank of New Zealand. The Group is having

constructive discussions with Bank of New Zealand regarding this breach and is preparing more information

for their consideration. The Group will then seek the agreement of Bank of New Zealand to either a waiver

or variation of the covenant. It is expected discussions to be concluded by the end of this calendar year. As

at the date of the signing of the these financial statements, no demand for repayment has been made.

It is the continuing opinion of the board of directors that there are reasonable grounds to believe that its

operational and financial plans in place are achievable, and accordingly the Group is able to continue as a

going concern and meet its debts as and when they fall due. Accordingly, use of the going concern

assumption remains appropriate in these circumstances.

(c) Segment reporting

The Group operates a number of rest homes and retirement villages. These facilities all provide a similar

product to a similar customer in the same regulatory environment.

The Group operates in one operating segment being the provision of aged-care in New Zealand. The chief

operating decision maker, the Board of Directors, reviews the operating results on a regular basis and

makes decisions on resource allocation based on the review of Group results and cash flows as a whole.

Therefore, it is appropriate to report solely on the Group performance.

30 September

2023

UNAUDITED

30 September

2022

UNAUDITED

31 March

2023

AUDITED

$ '000$ '000$ '000

NOTE 2: PROPERTY, PLANT AND EQUIPMENT

Land and buildings

At fair value17,26216,43717,261

Accumulated depreciation(927)(401)(714)

16,33516,03616,547

Plant and equipment

Other at cost1,9011,4611,724

Accumulated depreciation(535)(246)(361)

1,3661,2151,363

Total property, plant and equipment

17,70117,25117,910

- 7 -

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the six months ended 30 September 2023

13

INTERIM REPORT

PROMISIA HEALTHCARE LIMITED
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE 6 MONTHS ENDED 30 SEPTEMBER 2023

Note

30 September

2023

UNAUDITED

30 September

2022

UNAUDITED

31 March

2023

AUDITED

$ '000$ '000$ '000

NOTE 2: PROPERTY, PLANT AND EQUIPMENT (CONTINUED)

(a) Reconciliations

Reconciliation of the carrying amounts of property, plant

and equipment at the beginning and end of the current

financial period

Land and buildings at fair value

Opening carrying amount16,5473,1613,161

Additions513,18713,249

Net amount of revaluation increments less decrements--762

Depreciation expense(217)(312)(625)

Closing carrying amount

16,33516,03616,547

Other at cost

Opening carrying amount1,363939939

Additions172373637

Depreciation expense(169)(97)(213)

Closing carrying amount

1,3661,2151,363

NOTE 3: INVESTMENT PROPERTIES

During the period, investment properties have increased from $49.320m at 31 March 2023 to $52.646m at

30 September 2023 being an increase of $3.326m (2022: Increased from $42.015m at 31 March 2022 to

$43.275m at 30 September 2022 being an increase of $1.060m). This increase relates to further

development of the Ranfurly Manor Village located next to the Ranfurly Manor Residential Care Centre in

Fielding.

- 8 -

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the six months ended 30 September 2023

14

PROMISIA HEALTHCARE LIMITED

PROMISIA HEALTHCARE LIMITED
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE 6 MONTHS ENDED 30 SEPTEMBER 2023

Note

30 September

2023

UNAUDITED

30 September

2022

UNAUDITED

31 March

2023

AUDITED

$ '000$ '000$ '000

NOTE 4: BORROWINGS

Current portion19,931 477 11,727

Term portion

10,500 29,370 19,145

30,431 29,847 30,872

Comprises of:

- Advantage Finance540-1,040

- Hunter Funding Limited - insurance funding515120104

- Monument Finance Limited - insurance funding-26-

- BNZ - Aldwins House Limited7,5007,5007,500

- BNZ - Eileen Mary Age Care Property Limited2,9002,9002,900

- BNZ - Ranfurly Manor No: 1 Limited5,4305,4305,430

- BNZ - Ranfurly Manor No: 1 Limited1,5012,2011,853

- BNZ - Nelson Street Resthome Limited1,1701,1701,170

- Senior Trust- Ranfurly Manor No: 1 Limited6,5006,5006,500

- Teltower Limited4,0004,0004,000

- First Mortgage Trust375-375

30,43129,84730,872

BNZ Loans

On 16 November 2023, the Group advised that it had breached the EBITDA / Interest banking covenant for

the quarter ended 30 September 2023 for the BNZ loans. As the breach entitles BNZ to demand repayment,

the loans have been recorded as current. As at the date of the signing of these financial statements,

repayment has not been demanded and the Group is in discussions with BNZ to seek variation or waiver of

the covenant. The standard terms of the BNZ loan are as follows:

The term loans are secured by first mortgage security over the aged care facilities. The loans have interest

rates of2.29% to 9.79% at 30 September 2023 (30 September 2022: 5.15% to 7.57% and 31 March 2023:

2.29% to 9.13% p.a). BNZ loans consist of:

$1.5m (30 September 2022: $2.2m and 31 March 2023:$1.9m) with a maturity date of 30 October 2025

(30 September 2022: 30 October 2025 and 31 March 2023: 30 October 2025). The full amount of this

loan is current (30 September 2022: $700,470 and 31 March 2023: $708,000)

 $7.5m (23 September 2022: $7.5m and 31 March 2023: $7.5m) with a maturity date of 31 March 2025

(30 September 2022: 31 March 2025 and 31 March 2023: 31 March 2025)

 $9.5m (30 September 2022: $9.5m 31 March 2023: $9.5m) with a maturity date of 20 October 2023

(30 September 2022: 20 October 2023 and 31 March 2023: 20 October 2023)

There is an all obligations unlimited interlocking company guarantee between the following entities in the

Group; Eileen Mary Age Care Limited, Promisia Healthcare Limited, Aged Care Holdings Limited, Ranfurly

Manor Limited, Nelson Street Resthome Limited and Aldwins House Limited.

- 9 -

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the six months ended 30 September 2023

15

INTERIM REPORT

PROMISIA HEALTHCARE LIMITED
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE 6 MONTHS ENDED 30 SEPTEMBER 2023

NOTE 4: BORROWINGS (CONTINUED)

Advantage Finance Ltd

A loan of $1.0m was entered into during the year ended 31 March 2023. This loan has an interest rate of

12.0% p.a. Repayment in full was required by 27 November 2023. Subsequent to reporting date this was

extended to 27 March 2024. The loan is secured by 74 and 76 Aldwins Road, Christchurch.

Senior Trust

Senior Trust Retirement Village Income Generator Limited holds second mortgage security over the aged

care facilities. The loan is interest only with a fixed interest rate of 10.75% (30 Sep 2022: 10.75% and 31

March 2023: 10.75%) p.a. Repayment is required in full on 30 October 2024.

Teltower Limited Loan

A term loan of $4.0m was entered into during the year ended 31 March 2023. This loan has an interest rate

of 6.0% p.a. (30 September 2022: 6.0% p.a. 31 March 2023: 6.0% p.a.). Repayment is required in full on 1

April 2027. There is no commitment to repay principal until two years from term expiry (1 April 2025). The

loan is secured by the present properties at 56 McPhee Street, Dannevirke and 62 Aldwins Road,

Phillipstown as well as any after acquired property.

Insurance premium funding

Funding was provided by Hunter Funding Limited for the payment of insurance premiums during the

period. In the comparative period funding was provided by Monument Finance Limited.

First Mortage Trust

A loan of $0.4m was entered into during the year ended 31 March 2023. This is an interest only loan with

an interest rate of 8.75% p.a. (31 March 2023: 8.75% p.a.) The intial maturity date of the loan was 10

November 2023. Subsequent to reporting date this was extended to 10 March 2024 and the interest rate

was increased to 9.50%. The loan is secured by 60 Aldwins Road, Christchurch.

NOTE 5: SHARE CAPITAL

30 September 2023

UNAUDITED

30 September 2022

UNAUDITED

Number

(000's)$ '000

Number

(000's)$ '000

At reporting date

21,434,97577,42621,284,97577,276

The Group's share capital includes fully paid shares.

- 10 -

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the six months ended 30 September 2023

16

PROMISIA HEALTHCARE LIMITED

PROMISIA HEALTHCARE LIMITED
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE 6 MONTHS ENDED 30 SEPTEMBER 2023

Note

30 September

2023

UNAUDITED

30 September

2022

UNAUDITED

31 March

2023

AUDITED

$ '000$ '000$ '000

NOTE 6: RESERVES

Asset revaluation reserve667-667

Interest pooling reserve(717)(717)(717)

(50)(717)(50)

The interest pooling reserve has been used to record the value on acquisition of an aged care facility on 30

October 2020.

30 September

2023

UNAUDITED

30 September

2022

UNAUDITED

$ '000$ '000

NOTE 7: EARNINGS PER SHARE

Net gain/ (loss) from continuing operations(152)382


CentsCents

per share per share

Cents per share

Net gain/ (loss) from continuing operations(0.0007)0.0018


Number of Number of

shares shares

000's 000's

Weighted average number of shares for basic and diluted EPS21,434,97521,284,975

The calculation of basic earnings per share is based on the loss from continuing operations attributable to

ordinary shareholders and the weighted average of total ordinary shares on issue during the period. The

calculation of diluted earnings per share is the same calculation as basic earnings per share as there were

no share options to be exercised.

- 11 -

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the six months ended 30 September 2023

17

INTERIM REPORT

PROMISIA HEALTHCARE LIMITED
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE 6 MONTHS ENDED 30 SEPTEMBER 2023

30 September

2023

UNAUDITED

30 September

2022

UNAUDITED

$ '000$ '000

NOTE 8: RELATED PARTY TRANSACTIONS

Related PartyRelationship

Brankin Family Interest TrustRelated to a shareholder and a Director of the Group

(a) Transactions with related parties

Directors fees*(100)(88)

* Directors fees are paid monthly to all directors

(b) Balances with related parties

At reporting date $0.145m was receivable from Brankin Family Interest Trust (30 September 2022: $0.538m

and 31 March 2023: $0.145m).

During the year ended 31 March 2023 the Brankin Family Interest Trust paid taxes on behalf of the group

amounting to $0.175m. At reporting date $0.175m was payable (30 September 2022: $Nil and 31 March

2023: $0.175m).

No balances with related parties were written off or forgiven in the period.

NOTE 9: CAPITAL COMMITMENTS

The Group has entered into a fixed price agreement for the development land surrounding the Ranfurly

Residential Care Centre. The agreement, initially for 7 years was amended by a contract deed of variation on

6th December 2022, to a period of two years for the development of eight internal units, three 1-bedroom

villas and twenty two 2-bedroom villas to be completed at a fixed price of $12.06m to be paid from ORA

sale proceeds from individual units (30 September 2022: $14.18m and 31 March 2023: $12.06m). The

commitment as at 30 September 2023 is $6.29m (30 September 2022: $Nil and 31 March 2023: $9.13m)

As at 30 September 2023, all internal units, 1-bedroom villas and 2-bedroom villas had been completed.

Fourteen of the villas have been sold, with a further four sold post period end and five under offer. One of

the internal units was sold subsequent to reporting date.

NOTE 10: CONTINGENT LIABILITIES

There are no contingent liabilities at 30 September 2023. (30 September 2022: $Nil)

- 12 -

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the six months ended 30 September 2023

18

PROMISIA HEALTHCARE LIMITED

PROMISIA HEALTHCARE LIMITED
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE 6 MONTHS ENDED 30 SEPTEMBER 2023

NOTE 11: EVENTS SUBSEQUENT TO REPORTING DATE

There has been no matter or circumstance, which has arisen since

30 September 2023 that has significantly

affected or may significantly affect:

(a)the operations, in financial period subsequent to

30 September 2023, of the Group, or

(b)the results of those operations, or

(c)the state of affairs, in financial period subsequent to

30 September 2023, of the Group.

- 13 -

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the six months ended 30 September 2023

19

INTERIM REPORT

PROMISIA HEALTHCARE LIMITED
DIRECTORY

Registered office Duncan Cotterill

Level 5, 50 Customhouse Quay

Wellington, 6011

DirectorsThomas Brankin

Craig Percy

Helen Down (resigned 28 August 2023)

Rhonda Sherriff (appointed 13 July 2023)

Jill Hatchwell (appointed 28 August 2023)

AuditorWilliam Buck Audit (NZ) Limited

BankBank of New Zealand

Kiwibank

SolicitorsDuncan Cotterill, Wellington

- 1 -

DIRECTORY

20

PROMISIA HEALTHCARE LIMITED

www.promisia.co.nz

---

Market Announcement
28 November 2023

PROMISIA 1H24 INTERIM RESULTS


Promisia Healthcare Limited (NZX: PHL, “Promisia”) has announced its unaudited results for the six

months ended 30 September 2023 (1H24).

The company continues to focus on its commercial objectives, delivering increasing occupancy,

strong new villa sales and resales, and a relentless focus on high quality, personalised care.

Chair of Promisia, Rhonda Sherriff, commented: “Good progress is being made and Promisia is well

positioned to take advantage of market opportunities. Our business is in good shape, with a strong

and experienced Board and management team, and we are looking forward to delivering another

year of increased earnings and business growth in FY24.”

Six month strategic and financial snapshot:

 Welcomed new Board leadership with appointment of industry expert, Rhonda Sherriff, as

Chair, as well as Jill Hatchwell as Independent Director and Chair of the Audit and Risk

Management Committee

 Restructured and strengthened the leadership team with appointment of Karen Lake as

Group GM, along with a new GM of Finance and new Clinical and Quality Manager

• Review of strategy and re-set of objectives to drive commercial growth

• Continuing improvement in occupancy across the Group

• Continue to explore expansion and growth opportunities

• Revenue $12.9m, +11% yoy

• EBITDAF1 $1.6m, -11% yoy

• Net Loss After Tax $(152)k, down from a profit of $382k in prior year, reflecting one-off costs

associated with the leadership and Board transition

• Total assets $73.6m, +12% yoy

• Borrowings $30.4m, +2% yoy

For further information on Promisia’s six month performance, please read the Interim Report for the

six months ended 30 September 2023.

ENDS


Authority for this announcement: Rhonda Sherriff, Chair, Promisia Healthcare Limited

For more information, please contact: Jackie Ellis, +64 27 246 2505 or e: jackie@ellisandco.co.nz.


About Promisia Healthcare

Promisia is a New Zealand based aged care and retirement living provider, with a focus on delivering

quality personalised care. Our aim is to be the aged care provider of choice in our communities. Our

facilities are located in well-established and well serviced towns and metropolitan areas. Our goal is

to profitably grow our business in a sustainable manner, delivering quality care to our residents,

peace of mind to their families and whanau, and excellent value to our villages, community and

shareholders. Promisia is listed on the NZX (NZX: PHL). www.promisia.com

---

Results announcement
(for Equity Security issuer/Equity and Debt Security issuer)



Results for announcement to the market

Name of issuer Promisia Healthcare Limited

Reporting Period 6 months to 30 September 2023

Previous Reporting Period 6 months to 30 September 2022

Currency NZD

Amount (000s) Percentage change

Revenue from continuing

operations

$12,926 10.7%

Total Revenue $12,926 10.7%

Net profit/(loss) from

continuing operations

-$152 -139.8%

Total net profit/(loss) -$152 -139.8%

Interim/Final Dividend

Amount per Quoted Equity

Security

No dividend is proposed

Imputed amount per Quoted

Equity Security

Not Applicable

Record Date Not Applicable

Dividend Payment Date Not Applicable

Current period Prior comparable period

Net tangible assets per

Quoted Equity Security

$0.00091 $0.00087

A brief explanation of any of

the figures above necessary

to enable the figures to be

understood

Please see attached results announcement for commentary

on the result.

Authority for this announcement

Name of person


authorised

to make this announcement

Rhonda Sherriff, Chair

Contact person for this

announcement

Francisco Rodriguez Ferrere, General Manager Finance

Contact phone number 021 245 1801

Contact email address Francisco.rf@promisia.co.nz

Date of release through MAP


28/11/2023


Unaudited financial statements accompany this announcement.

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.